Alibaba Health Information Stock Performance
| ALBBY Stock | USD 9.22 0.16 1.77% |
On a scale of 0 to 100, Alibaba Health holds a performance score of 6. The firm shows a Beta (market volatility) of -0.85, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Alibaba Health are expected to decrease at a much lower rate. During the bear market, Alibaba Health is likely to outperform the market. Please check Alibaba Health's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Alibaba Health's price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alibaba Health Information are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Alibaba Health showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 7.3 B | |
| Total Cashflows From Investing Activities | 1.9 B |
Alibaba |
Alibaba Health Relative Risk vs. Return Landscape
If you would invest 752.00 in Alibaba Health Information on August 31, 2024 and sell it today you would earn a total of 170.00 from holding Alibaba Health Information or generate 22.61% return on investment over 90 days. Alibaba Health Information is currently producing 0.5208% returns and takes up 6.4958% volatility of returns over 90 trading days. Put another way, 57% of traded pink sheets are less volatile than Alibaba, and 90% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Alibaba Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alibaba Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Alibaba Health Information, and traders can use it to determine the average amount a Alibaba Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0802
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALBBY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.5 actual daily | 57 57% of assets are less volatile |
Expected Return
| 0.52 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Alibaba Health is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alibaba Health by adding it to a well-diversified portfolio.
Alibaba Health Fundamentals Growth
Alibaba Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Alibaba Health, and Alibaba Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alibaba Pink Sheet performance.
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 14.83 B | |||
| Shares Outstanding | 676.01 M | |||
| Price To Earning | 210.12 X | |||
| Price To Book | 8.08 X | |||
| Price To Sales | 0.66 X | |||
| Revenue | 20.58 B | |||
| EBITDA | (248.7 M) | |||
| Cash And Equivalents | 10.55 B | |||
| Cash Per Share | 15.64 X | |||
| Total Debt | 135.41 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 22.12 X | |||
| Cash Flow From Operations | 424.36 M | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 19.2 B | |||
About Alibaba Health Performance
Evaluating Alibaba Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Alibaba Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Alibaba Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong. Alibaba Health operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 1849 people.Things to note about Alibaba Health Infor performance evaluation
Checking the ongoing alerts about Alibaba Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Alibaba Health Infor help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alibaba Health Infor is way too risky over 90 days horizon | |
| Alibaba Health Infor appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 20.58 B. Net Loss for the year was (265.56 M) with profit before overhead, payroll, taxes, and interest of 4.11 B. |
- Analyzing Alibaba Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alibaba Health's stock is overvalued or undervalued compared to its peers.
- Examining Alibaba Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alibaba Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alibaba Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alibaba Health's pink sheet. These opinions can provide insight into Alibaba Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Alibaba Pink Sheet Analysis
When running Alibaba Health's price analysis, check to measure Alibaba Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alibaba Health is operating at the current time. Most of Alibaba Health's value examination focuses on studying past and present price action to predict the probability of Alibaba Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alibaba Health's price. Additionally, you may evaluate how the addition of Alibaba Health to your portfolios can decrease your overall portfolio volatility.